We have several purchase plans based on your needs. Make sure you are on our mailing list to receive further information.

Your IpsiHand may be covered by insurance.

Neurolutions assists stroke survivors with obtaining insurance coverage and reimbursement for IpsiHand.

In order to provide these services on your behalf, Neurolutions must obtain and share certain information about you from your doctor, other health care providers, and each of your health insurers.

The Neurolutions IpsiHand system is a qualified medical expense under a heath savings account (HSA) or flexible spending account (FSA). Please verify your eligibility by checking with your individual plan.

We plan to launch future clinical trials. Make sure you are on our mailing list to receive updates about our clinical trials.

Currently, the IpsiHand is indicated for chronic stroke survivors with upper limb weakness due to stroke.

Currently, the IpsiHand is indicated for use in adults age 18 and older, as the IpsiHand has not been studied in the pediatric population.

No, we can work with your clinician if you are currently enrolled in a rehabilitation therapy program. In addition, our Clinical Team consists of experienced Occupational Therapists with advanced certifications to provide you with assistance and information for screening and set-up of the IpsiHand System.

One hundred percent of clinical trial participants saw an improvement in their arm and/or hand function following participation in the study. Our clinical trials demonstrated clinically significant arm and hand improvement for 66.7% of trial participants. The IpsiHand study protocols required the use of the device approximately 1 hour per day, 5 to 7 days a week for a total of at least 12 weeks in patients 6 or more months post-stroke. Participants in our clinical trials used the IpsiHand system at home for the duration of the study.

Currently, the IpsiHand is indicated for chronic stroke survivors with upper limb weakness due to stroke.

Currently, the IpsiHand is indicated for use in adults age 18 and older, as the IpsiHand has not been studied in the pediatric population.

DO I QUALIFY?

We plan to launch future clinical trials. Make sure you are on our mailing list to receive updates about our clinical trials.

No, we can work with your clinician if you are currently enrolled in a rehabilitation therapy program. In addition, our Clinical Team consists of experienced Occupational Therapists with advanced certifications to provide you with assistance and information for screening and set-up of the IpsiHand System.

One hundred percent of clinical trial participants saw an improvement in their arm and/or hand function following participation in the study. Our clinical trials demonstrated clinically significant arm and hand improvement for 66.7% of trial participants. The IpsiHand study protocols required the use of the device approximately 1 hour per day, 5 to 7 days a week for a total of at least 12 weeks in patients 6 or more months post-stroke. Participants in our clinical trials used the IpsiHand system at home for the duration of the study.

The reason we call it the IpsiHand is because the prefix “ipsi” means the same. After a stroke occurs on one side of your brain, affecting the opposite side of your body causing weakness.

For example, if the stroke occurred on the left side of your brain, you may have weakness or spastic muscles on the right side of your body. The IpsiHand may train your brain to control the hand on the same side that the brain wave is coming from.

FDA De Novo approval establishes a new medical device type and approves that the device is safe to be used. De Novo classified devices did not fit into an established category and there were no equivalent devices on the market at the time of approval.